Texas biotech company IDEV Technologies is making its mark in medical technology as “architects of intervention,” as their motto claims. One of their most recent innovations, the Supera stent, has shown promising results in two recent long-term studies performed by different organizations.
http://www.swbiosearch.com/2013/02/06/two-positive-studies-offer-promising-results-for-texas-biotech-business/
No comments:
Post a Comment